New research indicates that individuals who come off popular slimming jabs like semaglutide or tirzepatide may regain lost weight much more quickly than those who halt conventional lifestyle regimens.
Research printed in a leading health publication demonstrates that while overweight individuals frequently drop a large proportion of their body weight while using the jabs, the weight is regained at an estimated rate of 0.8 kg per month once they quit.
"Individuals purchasing such medications should be cognizant of the potential of quick rebound weight gain when the treatment is stopped," warns researcher Dr. Susan Jebb.
Such speed of recovery implies a return to starting mass within about 18 months.
Weighing Approaches
The analysis, which looked at dozens of trials involving thousands of patients, contrasted the outcomes of GLP-1 agonists with other pills.
The team emphasize that individuals who lose weight through diet and exercise usually have a less rapid weight regain—approximately 100 grams monthly—once they finish.
Understanding the Quick Rebound
Doctors believe the way of the jabs accounts for the amplified rebound.
GLP-1 drugs imitate a natural hormone called GLP-1, which helps regulate hunger.
"Sustained high doses of the hormone concentrations several times higher than normal might result in the body to produce less of its own natural hormone, and could reduce sensitivity to its effects," explained Dr. Adam Collins, a nutrition expert.
"Stopping of this medication leads to hunger is no longer kept in check, making excessive eating much more probable."
A Chronic Issue?
Medical guidelines suggest the injections for people with weight-linked health risks, alongside recommended diet and exercise modifications.
A number of clinicians contend that, considering the likelihood of weight regain, the treatment should be considered life-long.
This perspective is reinforced by drug manufacturers, who state that the results "underscore the long-term character of obesity," akin to managing conditions like diabetes.
Patient Accounts
People who have stopped the jabs explain a sudden resurgence of cravings.
"It felt as if a trigger activating and you become extremely hungry," described a patient.
The struggle is exacerbated if users have not developed sustainable dietary or behavioural modifications during treatment.
Growing Use
Figures suggest that a significant number of adults in the UK have tried these injections in the last 12 months, with desire continuing to grow.
- Use is higher among females than men.
- The middle-aged age group shows the greatest usage rates.
- Many access the drugs through private healthcare rather than the NHS.
Finally, clinicians emphasize that while these medications are powerful agents for shedding pounds, they are not a standalone solution and lasting health benefits hinges on integrated lifestyle management.
